- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Arcadia Biosciences Inc (RKDA)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/04/2025: RKDA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $12
1 Year Target Price $12
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -54.53% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.03M USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 1 | Beta 0.48 | 52 Weeks Range 2.53 - 6.44 | Updated Date 12/4/2025 |
52 Weeks Range 2.53 - 6.44 | Updated Date 12/4/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.69 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-10 | When - | Estimate -0.54 | Actual 0.62 |
Profitability
Profit Margin -97.95% | Operating Margin (TTM) -88.48% |
Management Effectiveness
Return on Assets (TTM) -31.48% | Return on Equity (TTM) -64.65% |
Valuation
Trailing PE - | Forward PE 36.63 | Enterprise Value 593893 | Price to Sales(TTM) 0.97 |
Enterprise Value 593893 | Price to Sales(TTM) 0.97 | ||
Enterprise Value to Revenue 0.11 | Enterprise Value to EBITDA 0.62 | Shares Outstanding 1373120 | Shares Floating 1361902 |
Shares Outstanding 1373120 | Shares Floating 1361902 | ||
Percent Insiders 0.82 | Percent Institutions 4.77 |
Upturn AI SWOT
Arcadia Biosciences Inc

Company Overview
History and Background
Arcadia Biosciences, Inc. was founded in 2004. It focuses on developing and marketing crop traits and products aimed at improving human and environmental well-being. Initially focused on traits for crops like wheat and soybeans, it has shifted towards consumer-facing products and ingredients.
Core Business Areas
- GoodWheat: Arcadia's portfolio of wheat varieties with improved characteristics such as high fiber and reduced gluten. These are sold to food companies and consumers.
- Arcadia Consumer Health: This segment focuses on consumer products, including Zola coconut water and other health and wellness brands. This segment appears to be divested.
- CBD: While previously exploring CBD-related opportunities, it appears Arcadia has divested from this and focuses on their GoodWheat product line
Leadership and Structure
The leadership team includes Stan Jacot as CEO. The organizational structure is typical of a publicly traded company, with a board of directors overseeing management.
Top Products and Market Share
Key Offerings
- GoodWheat: GoodWheat offers various traits like high fiber and reduced gluten in wheat. Market share information specific to GoodWheat is difficult to ascertain. Competitors include traditional wheat breeders and companies focused on modifying crop traits for health benefits. Revenue figures fluctuate but are the core revenue driver. Large competitors in the broader crop trait space are companies like Bayer and Corteva.
Market Dynamics
Industry Overview
The agricultural biotechnology industry is characterized by innovation in crop traits, increasing demand for healthier and more sustainable food options, and regulatory scrutiny. It is also marked by increasing competition and consolidation. Consumer preferences for healthier ingredients drive demand.
Positioning
Arcadia Biosciences is positioned as a developer of innovative crop traits and consumer products that address health and sustainability. Its competitive advantage lies in its proprietary technologies and focused product portfolio. It is smaller than its large competitors.
Total Addressable Market (TAM)
The total addressable market for enhanced wheat varieties is substantial, driven by the global consumption of wheat. Exact figures are hard to quantify. Arcadia is positioning itself to capture a segment of this market through its GoodWheat products.
Upturn SWOT Analysis
Strengths
- Proprietary wheat technology
- Focus on healthier food options
- Consumer-facing brand
- Strong IP portfolio
Weaknesses
- Limited financial resources
- Reliance on a narrow product portfolio
- Relatively small scale of operations
- History of losses
Opportunities
- Growing demand for healthier food
- Expanding partnerships with food companies
- Further development of wheat traits
- Increasing consumer awareness
Threats
- Competition from larger agricultural companies
- Regulatory hurdles for genetically modified crops
- Fluctuations in commodity prices
- Changing consumer preferences
Competitors and Market Share
Key Competitors
- BGNE
- DWAC
- INPX
- SENS
Competitive Landscape
Arcadia faces significant competition from larger, more established agricultural companies. It must differentiate itself through innovative products and strategic partnerships.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been inconsistent, with periods of expansion followed by contractions.
Future Projections: Future growth projections are dependent on successful commercialization of its GoodWheat products and the company's ability to secure partnerships. Analyst estimates are needed for accurate projections.
Recent Initiatives: Recent initiatives focus on expanding the distribution and use of its GoodWheat products in various food applications.
Summary
Arcadia Biosciences is a small company with innovative wheat products aimed at health-conscious consumers. It has struggled with profitability and faces intense competition. The success of the company depends on the adoption of their GoodWheat products and the execution of their commercial strategies. They need to shore up financials.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Arcadia Biosciences Investor Relations
- SEC Filings
- Third-party market research reports
- Yahoo Finance
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It should not be considered financial advice. Market share data is often estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Arcadia Biosciences Inc
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2015-05-15 | CEO, Interim CFO, Principal Accounting Officer, President & Director Mr. Thomas J. Schaefer C.F.A. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 9 | Website https://www.arcadiabio.com |
Full time employees 9 | Website https://www.arcadiabio.com | ||
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

